Nurse Practitioner, Family · Spokane, WA
NPI
1275708240
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
101 W 8th Ave Ste 1400
Spokane, WA, 99204
Phone (509) 474-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
383 services
Medicare patients, 2024
161
Average age 74
Drug cost, 2024
$364K
449 prescriptions
Company payments, 2025
$27.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary S Foutz was code 99214 (office e&m - established), 159 times for 48 patients. In total Mary S Foutz billed 383 services in 12 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 159 | 48 | $78.35 | $12K |
| 99213 Office E&M - Established | Office | 147 | 116 | $49.62 | $7,294 |
| 81003 Clinical Chemistry | Office | 33 | 11 | $2.20 | $72.6 |
| 99215 Office E&M - Established | Office | 25 | 19 | $116.72 | $2,918 |
By year: 2022 $31K for 536 services; 2023 $29K for 482 services; 2024 $24K for 383 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 33 | 11 | $2.20 | $72.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary S Foutz prescribed most often to Medicare patients was Prochlorperazine Maleate, with 57 prescriptions and refills. In total Mary S Foutz wrote 449 Medicare prescriptions that cost $364K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 57 | 57 | 34 | $591 |
| Ondansetron Odt Ondansetron | 45 | 45 | 35 | $409 |
| Dexamethasone Generic | 38 | 46 | 35 | $421 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 34 | 35 | 29 | $467 |
| Oxycodone Hcl Generic | 20 | 20 | Under 11 | $166 |
| Gabapentin Generic | 18 | 18 | Under 11 | $87.74 |
| Letrozole Generic | 15 | 23 | Under 11 | $273 |
| Potassium Chloride Generic | 15 | 15 | Under 11 | $109 |
| Levothyroxine Sodium Generic | 14 | 14 | Under 11 | $16.65 |
| Hydromorphone Hcl Generic | 12 | 12 | Under 11 | $273 |
| Rubraca Rucaparib Camsylate | 11 | 11 | Under 11 | $222K |
Brand drugs: 53 claims; generic drugs: 396 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary S Foutz $27.78 ($27.78 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $27.78.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $27.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.